Practical Guideline for collaborative interventions
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
2016 Update
Key population
Guidelines
Key Populations
Putting Asia’s HIV response back on track
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...results at the national, regional and global levels.
This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years.
more
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...n randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy.
more
PQDx 0027-012-00 WHO
PQDx Public Report
May/2017, version 4.0
Vision 2030
Accessed: 17.11.2019
Policy
July 2012
Working Paper No. 3
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7